Author: Ronderos Botero, Diana Maria; Omar, Alaa Mabrouk Salem; Sun, Haozhe Keith; Mantri, Nikhitha; Fortuzi, Ked; Choi, Yongsub; Adrish, Muhammad; Nicu, Marin; Bella, Jonathan N.; Chilimuri, Sridhar
Title: COVID-19 in the Healthy Patient Population: Demographic and Clinical Phenotypic Characterization and Predictors of In-Hospital Outcomes Cord-id: m8p9xnfu Document date: 2020_9_10
ID: m8p9xnfu
Snippet: Coronavirus disease 2019 (COVID-19) can infect patients in any age group including those with no comorbid conditions. Understanding the demographic, clinical, and laboratory characteristics of these patients is important toward developing successful treatment strategies. APPROACH AND RESULTS: In a retrospective study design, consecutive patients without baseline comorbidities hospitalized with confirmed COVID-19 were included. Patients were subdivided into ≤55 and >55 years of age. Predictors
Document: Coronavirus disease 2019 (COVID-19) can infect patients in any age group including those with no comorbid conditions. Understanding the demographic, clinical, and laboratory characteristics of these patients is important toward developing successful treatment strategies. APPROACH AND RESULTS: In a retrospective study design, consecutive patients without baseline comorbidities hospitalized with confirmed COVID-19 were included. Patients were subdivided into ≤55 and >55 years of age. Predictors of in-hospital mortality or mechanical ventilation were analyzed in this patient population, as well as subgroups. Stable parameters in overall and subgroup models were used to construct a cluster model for phenotyping of patients. Of 1207 COVID-19–positive patients, 157 met the study criteria (80≤55 and 77>55 years of age). Most reliable predictors of outcomes overall and in subgroups were age, initial and follow-up d-dimer, and LDH (lactate dehydrogenase) levels. Their predictive cutoff values were used to construct a cluster model that produced 3 main clusters. Cluster 1 was a low-risk cluster and was characterized by younger patients who had low thrombotic and inflammatory features. Cluster 2 was intermediate risk that also consisted of younger population that had moderate level of thrombosis, higher inflammatory cells, and inflammatory markers. Cluster 3 was a high-risk cluster that had the most aggressive thrombotic and inflammatory feature. CONCLUSIONS: In healthy patient population, COVID-19 remains significantly associated with morbidity and mortality. While age remains the most important predictor of in-hospital outcomes, thromboinflammatory interactions are also associated with worse clinical outcomes regardless of age in healthy patients. GRAPHIC ABSTRACT: A graphic abstract is available for this article.
Search related documents:
Co phrase search for related documents- abnormal value and admission laboratory: 1, 2
- abnormal value and liver disease: 1, 2, 3
- abnormal value and liver function: 1, 2, 3, 4, 5, 6, 7
- abnormal value and liver function test: 1
- acute phase and admission day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute phase and admission laboratory: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute phase and liver disease: 1, 2, 3, 4, 5, 6
- acute phase and liver function: 1, 2, 3, 4, 5, 6, 7
- acute phase and low hemoglobin: 1
- acute phase and low lymphocyte count: 1, 2
- acute phase reactant and admission day: 1
- acute phase reactant and admission laboratory: 1, 2, 3
- admission day and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- admission day and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- admission day and liver function test: 1, 2
- admission day and low lymphocyte count: 1, 2, 3
- admission laboratory and liver function test: 1, 2, 3
- admission laboratory and low hemoglobin: 1
- admission laboratory and low lymphocyte count: 1, 2
Co phrase search for related documents, hyperlinks ordered by date